Skip to main content
. 2021 Apr 26;10(9):1869. doi: 10.3390/jcm10091869

Table 1.

Comparison of clinical variables and hypoperfusion intensity ratio between patients with and without favorable outcome.

Variables All Patients
(n = 162)
Favorable Outcome
(n = 85)
Unfavorable Outcome
(n = 77)
p-Value
Age 70.7 (± 12.8) 67.6 (± 12.9) 74.1 (± 11.8) 0.001
Sex, male 84 (51.9) 48 (56.5) 36 (46.8) 0.216
Hypertension 122 (75.3) 65 (76.5) 57 (74.0) 0.719
Diabetes 75 (46.3) 31 (36.5) 44 (57.1) 0.008
Hypercholesterolemia 77 (47.5) 39 (45.9) 38 (49.4) 0.659
Smoking 31 (19.1) 21 (24.7) 10 (13.0) 0.058
Coronary artery disease 29 (17.9) 19 (22.4) 11 (14.3) 0.187
Atrial fibrillation 80 (49.4) 38 (44.7) 42 (54.5) 0.211
Occlusion site 0.406
Internal carotid artery 64 (39.5) 31 (36.5) 33 (42.9)
Middle cerebral artery 98 (60.5) 54 (63.5) 44 (57.1)
Initial NIHSS score 15.0 [11.0; 19.8] 12.0 [7.0; 16.0] 19.0 [15.0; 20.0] <0.001
Use of intravenous tPA 78 (48.1) 50 (58.8) 28 (36.4) 0.004
ASPECTS 7.0 [5.0; 9.0] 8.0 [7.0; 9.0] 6.0 [4.0; 7.0] <0.001
Onset-to-recanalization, min 298.5 [197.0; 583.5] 274.0 [190.0; 434.0] 336.0 [212.0; 674.0] 0.045
Symptomatic ICH 10 (6.2) 4 (4.7) 6 (7.8) 0.520
Volume of rCBF < 30% (mm3) 33.7 (± 53.6) 12.0 (± 21.7) 57.6 (± 66.7) <0.001
Volume of Tmax > 6 s (mm3) 160.8 (± 76.7) 140.4 (± 67.6) 183.2 (± 80.2) <0.001
Hypoperfusion intensity ratio 0.51 [0.29; 0.68] 0.45 [0.15; 0.54] 0.60 [0.44; 0.73] <0.001

Values in parentheses represent the standard deviation (±) or number of patients (%); brackets represent first and third quartiles, respectively. NIHSS, National Institutes of Health Stroke Scale; tPA, tissue plasminogen activator; ASPECTS, Alberta Stroke Program Early Computed Tomography Score; ICH, intracerebral hemorrhage; rCBF, relative cerebral blood flow.